We’re turning water into wisdom at HLTH USA. Right now, Verily is monitoring pathogens in the community wastewater in the surrounding Las Vegas area to help inform public health response to infectious disease.
Nothing is more important than protecting a patient’s health data, which is why healthcare companies must have a robust data infrastructure designed for security protection. At Verily, privacy and security are embedded into the design, development and maintenance of our products and infrastructure. 🔒 We’ve implemented numerous layers of controls around the data of our users, customers, and partners, such as strong encryption and tightly restricted and closely monitored role-based access. 🔒 We also empower users to control access to their data according to their own preferences.
Navigating the digital era of health is challenging, but there are opportunities to implement a scalable plan while balancing innovation and impact. Listen in as Verily’s Sarah Thompson, Rasu Shrestha MD MBA, and Mona Siddiqui explore best practices during the HLTH USA Partner Program, hosted by Digital Medicine Society (DiMe), on Sunday, October 20 at 11:00 am.
Through timely community-level detection and quantification, Verily Sightline Wastewater monitoring quickly detects emerging diseases, including the H5 subtype of influenza, and Mpox
As digital biomarkers and measures are increasingly used in cardiovascular research and care, it is essential that we better understand potential sources of bias or inaccurate measurement. In collaboration with co-authors from University of Michigan Medical School, Verily researchers conducted a review of how skin tone may impact the accuracy of photoplethysmography (PPG), which is used in pulse oximetry devices and wearables to assess blood oxygenation (SpO2) and pulse rate (PR). The results show significant discrepancies in the accuracy of FDA-cleared pulse oximeters and commercially available wearable devices across skin tone. The authors share 5 recommendations to improve analytical validation of these devices. Verily is committed to representing all skin tones in our research through the work we’re doing with our digital biomarkers program and Health Equity Center of Excellence (https://veri.ly/3BOBIV7). We can then use these learnings to prevent any bias during our algorithm development, so that our digital measures generalize to all segments of the population.
Today on hashtag#WorldSightDay, we recognize the importance of discussing eye health with your healthcare provider. Learn about Verily Numetric Retinal Service, our end-to-end retinal screening solution that enables greater access to precision retinal imaging.
Exciting news for the future of biomedical research announced today! A Verily-led data and technology consortium made up of DataTecnica LLC, Technome, Sage Bionetworks, the Broad Institute of MIT and Harvard, Vanderbilt University Medical Center, and Northwestern University - The Feinberg School of Medicine, has received a $4.8M initial award from The National Institutes of Health’s Common Fund Venture Program to deliver a data platform powering systems biology research across Accelerating Medicines Partnership® programs. The centralized portal and tools, called SysBio FAIRplex, will enable researchers to analyze multi-modal data from 10+ conditions, advancing understanding of the complex mechanisms of diseases.
Recently, we introduced Verily Lightpath, a chronic care platform that will turn health data into personalized, proactive care to help people with diabetes, obesity and other metabolic conditions live healthier lives. It will be available in early 2026, but you can experience the features and capabilities at HLTH USA. See us in meeting room 2303 for a first-hand look.
We were honored to attend MDSCongress and present results from our recent study on Verily Study Watch-based digital measures that can track physical activity changes in people with early-stage Parkinson's Disease. ▶ Developing composite measures that track physical activity change in people with early-stage Parkinson’s disease using machine learning and wearable sensors https://bit.ly/3Bx2Hoi ▶ Proposed framework to evaluate the ability of digital measures to track early stage Parkinson’s disease progression https://bit.ly/3Yc2j7F
¡Verdad! is Verily’s newest employee resource group (ERG), formed in the last year to connect Hispanic/Latinx Veeps and allies, and to help foster a diverse and inclusive workplace for all. They aim to create a supportive space and opportunities that empower ERG members to grow both personally and professionally. Recently, ¡Verdad! joined X, the moonshot factory, Wing, Waymo and Intrinsic at Culinary Crossroads, an Alphabet Inc.-sponsored gathering to celebrate the intersection of Black and Hispanic/Latin culture through food, music, and games.
